John P A Ioannidis

发表

Dynamics of co-authorship and productivity across different fields of scientific research

Austin J Parish, Kevin W Boyack, John P A Ioannidis, 2018, PloS one.

Ethics and Epistemology in Big Data Research

John P A Ioannidis, Wendy Lipworth, Paul H Mason, 2017, Journal of Bioethical Inquiry.

Signals Among Signals: Prioritizing Nongenetic Associations in Massive Data Sets

John P A Ioannidis, Chirag J Patel, Arjun K Manrai, 2019, American journal of epidemiology.

METRADISC-XL: A program for meta-analysis of multidimensional ranked discovery oriented datasets including microarrays

John P A Ioannidis, Elias Zintzaras, J. Ioannidis, 2012, Comput. Methods Programs Biomed..

RESEARCH METHODS & REPORTING

John P A Ioannidis, J. Ioannidis, 2013 .

Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement.

Raluca Mihaescu, John P A Ioannidis, Muin J Khoury, 2014, Journal of clinical epidemiology.

Exposure‐wide epidemiology: revisiting Bradford Hill

John P A Ioannidis, J. Ioannidis, 2016, Statistics in medicine.

Predicting death: an empirical evaluation of predictive tools for mortality.

John P A Ioannidis, Ioanna Tzoulaki, George C M Siontis, 2011, Archives of internal medicine.

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

Gary S Collins, Karel G M Moons, Douglas G Altman, 2015, Annals of Internal Medicine.

Demystifying trial networks and network meta-analysis

Kristian Thorlund, John P A Ioannidis, Edward J Mills, 2013, BMJ.

Poor performance of clinical prediction models: the harm of commonly applied methods.

Ewout W Steyerberg, John P A Ioannidis, Hajime Uno, 2017, Journal of clinical epidemiology.

Discussion: Why "An estimate of the science-wise false discovery rate and application to the top medical literature" is false.

John P A Ioannidis, J. Ioannidis, 2014, Biostatistics.

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI).

John P A Ioannidis, Paolo Fusar-Poli, Eduard Vieta, 2019, Journal of visualized experiments : JoVE.

Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness

Gary S Collins, Rayid Ghani, Harry Hemingway, 2020, BMJ.

Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience.

John P A Ioannidis, Harald Mischak, Antonia Vlahou, 2013, Clinical biochemistry.

Strengthening the reporting of genetic risk prediction studies: the GRIPS statement

John P A Ioannidis, Muin J Khoury, Julian Little, 2011, Genome Medicine.

Translation of highly promising basic science research into clinical applications.

John P A Ioannidis, Despina G Contopoulos-Ioannidis, Evangelia Ntzani, 2003, The American journal of medicine.

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.

Georgia Salanti, John P A Ioannidis, A E Ades, 2011, Journal of clinical epidemiology.

Why replication has more scientific value than original discovery

John P A Ioannidis, J. Ioannidis, 2018, Behavioral and Brain Sciences.

Combining molecular and genetic data from different sources.

John P A Ioannidis, Muin J Khoury, Evangelia E Ntzani, 2011, IARC scientific publications.

Improving Validation Practices in “Omics” Research

John P A Ioannidis, Muin J Khoury, J. Ioannidis, 2011, Science.

Evaluating novel agent effects in multiple‐treatments meta‐regression

Nicky J Welton, Sofia Dias, Georgia Salanti, 2010, Statistics in medicine.

The Complexities of Evaluating the Exposome in Psychiatry: A Data-Driven Illustration of Challenges and Some Propositions for Amendments

John P A Ioannidis, Sinan Guloksuz, Jim van Os, 2018, Schizophrenia bulletin.

Informed Consent, Big Data, and the Oxymoron of Research That Is Not Research

John P A Ioannidis, J. Ioannidis, 2013, The American journal of bioethics : AJOB.

Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study

Andres Metspalu, Michael Doherty, Nigel Arden, 2012, The Lancet.

Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies.

Kristian Thorlund, John P A Ioannidis, Edward J Mills, 2012, Journal of clinical epidemiology.

Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments.

Georgia Salanti, John P A Ioannidis, J. Ioannidis, 2006, Journal of the National Cancer Institute.

Multiple Citation Indicators and Their Composite across Scientific Disciplines

Kevin W Boyack, John P A Ioannidis, Richard Klavans, 2016, PLoS biology.

Is everything we eat associated with cancer? A systematic cookbook review.

John P A Ioannidis, Jonathan D Schoenfeld, J. Ioannidis, 2013, The American journal of clinical nutrition.

Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects.

John P A Ioannidis, Tiago V Pereira, J. Ioannidis, 2011, Journal of clinical epidemiology.

A road map for efficient and reliable human genome epidemiology

Paolo Vineis, Molly S Bray, Julian P T Higgins, 2006, Nature Genetics.

Modern health care as a game theory problem

John P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic, 2015, European journal of clinical investigation.

Excess significance bias in the literature on brain volume abnormalities.

John P A Ioannidis, J. Ioannidis, 2011, Archives of general psychiatry.

Double Versus Single Stenting for Coronary Bifurcation Lesions: A Meta-Analysis

John P A Ioannidis, George C M Siontis, Demosthenes G Katritsis, 2009, Circulation. Cardiovascular interventions.

Overinterpretation of clinical applicability in molecular diagnostic research.

John P A Ioannidis, Marina Pollán, Miquel Porta, 2009, Clinical chemistry.

Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification

John P A Ioannidis, Kee Seng Chia, Richie Poulton, 2009, Science Translational Medicine.

Systematic assessment of the correlations of household income with infectious, biochemical, physiological, and environmental factors in the United States, 1999-2006.

John P A Ioannidis, Chirag J Patel, Mark R Cullen, 2015, American journal of epidemiology.

Empirical evaluation of very large treatment effects of medical interventions.

John P A Ioannidis, Tiago V Pereira, Ralph I Horwitz, 2012, JAMA.

Clinical outcome prediction by microRNAs in human cancer: a systematic review.

John P A Ioannidis, J. Ioannidis, V. Nair, 2012, Journal of the National Cancer Institute.

Diagnostic tests often fail to lead to changes in patient outcomes.

John P A Ioannidis, Despina G Contopoulos-Ioannidis, George C M Siontis, 2014, Journal of clinical epidemiology.

Placing epidemiological results in the context of multiplicity and typical correlations of exposures

John P A Ioannidis, Chirag J Patel, J. Ioannidis, 2014, Journal of Epidemiology & Community Health.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Paolo Vineis, David H Phillips, Christopher Wild, 2011, Mutagenesis.

Perfect study, poor evidence: interpretation of biases preceding study design.

John P A Ioannidis, J. Ioannidis, 2008, Seminars in hematology.

Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study

Nazmus Saquib, John P A Ioannidis, Juliann Saquib, 2013, BMJ.

Multivariate models of self-reported health often neglected essential candidate determinants and methodological issues.

John P A Ioannidis, Ioannis D K Dimoliatis, J. Ioannidis, 2005, Journal of clinical epidemiology.

Prevalence and outcomes of incidental imaging findings: umbrella review

John P A Ioannidis, Sam Grigg, Tim Muntinga, 2018, British Medical Journal.

Neglecting Major Health Problems and Broadcasting Minor, Uncertain Issues in Lifestyle Science.

John P A Ioannidis, J. Ioannidis, 2019, JAMA.

How to use an article about genetic association: B: Are the results of the study valid?

Ammarin Thakkinstian, Mark McEvoy, Rodney J Scott, 2009, JAMA.

Noninferiority is almost certain with lenient noninferiority margins.

John P A Ioannidis, Lamberto Manzoli, J. Ioannidis, 2016, Journal of clinical epidemiology.

New Prognostic Markers for Outcome of Acute Pancreatitis: Overview of Reporting in 184 Studies

John P A Ioannidis, Athina Tatsioni, J. Ioannidis, 2011, Pancreas.

John P A Ioannidis, Despina Koletsi, Nikolaos Pandis, 2019, International journal of epidemiology.

Heterogeneity testing in meta‐analysis of genome searches

John P A Ioannidis, Elias Zintzaras, J. Ioannidis, 2005, Genetic epidemiology.

Evaluation of Wellness Determinants and Interventions by Citizen Scientists.

John P A Ioannidis, Huseyin Naci, J. Ioannidis, 2015, JAMA.

Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine

David Moher, John P A Ioannidis, Daniele Fanelli, 2018, British Medical Journal.

The Importance of Predefined Rules and Prespecified Statistical Analyses: Do Not Abandon Significance.

John P A Ioannidis, J. Ioannidis, 2019, JAMA.

Effect of formal statistical significance on the credibility of observational associations.

John P A Ioannidis, J. Ioannidis, 2008, American journal of epidemiology.

Professional Societies Should Abstain From Authorship of Guidelines and Disease Definition Statements.

John P A Ioannidis, J. Ioannidis, 2018, Circulation. Cardiovascular quality and outcomes.

On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies.

John P A Ioannidis, Muin J Khoury, Marta Gwinn, 2007, International journal of epidemiology.

Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations.

John P A Ioannidis, Chirag J Patel, Belinda Burford, 2015, Journal of clinical epidemiology.

The Challenge of Reforming Nutritional Epidemiologic Research.

John P A Ioannidis, J. Ioannidis, 2018, JAMA.

Reanalyses of randomized clinical trial data.

Kristian Thorlund, John P A Ioannidis, Edward J Mills, 2014, JAMA.

Selective reporting biases in cancer prognostic factor studies.

John P A Ioannidis, J. Ioannidis, P. Kyzas, 2005, Journal of the National Cancer Institute.

Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials.

Ethan M Balk, Joseph Lau, John P A Ioannidis, 2002, JAMA.

To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication?

John P A Ioannidis, J. Ioannidis, 2013, Circulation. Cardiovascular genetics.

Commentary: Adjusting for bias: a user's guide to performing plastic surgery on meta-analyses of observational studies.

John P A Ioannidis, J. Ioannidis, 2011, International journal of epidemiology.

Stealth research: is biomedical innovation happening outside the peer-reviewed literature?

John P A Ioannidis, J. Ioannidis, 2015, JAMA.

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

Kristian Thorlund, John P A Ioannidis, Christian Gluud, 2009, International journal of epidemiology.

Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.

John P A Ioannidis, Evangelos Evangelou, Ioanna Tzoulaki, 2016, Parkinsonism & related disorders.

Human Genome Sequencing at the Population Scale: A Primer on High-Throughput DNA Sequencing and Analysis

Euan A Ashley, John P A Ioannidis, Muin J Khoury, 2017, American journal of epidemiology.

Academic criteria for appointment, promotion and rewards in medical research: where's the evidence?

David Moher, John P A Ioannidis, Steven N Goodman, 2016, European journal of clinical investigation.

A list of highly influential biomedical researchers, 1996–2011

Kevin W Boyack, John P A Ioannidis, Richard Klavans, 2013, European journal of clinical investigation.

Understanding and harnessing the health effects of rapid urbanization in China.

Francis L Martin, John P A Ioannidis, Kevin C Jones, 2011, Environmental science & technology.

Required sample size and nonreplicability thresholds for heterogeneous genetic associations

John P A Ioannidis, Muin J Khoury, J. Ioannidis, 2008, Proceedings of the National Academy of Sciences.

Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists.

John P A Ioannidis, J. Ioannidis, O. Panagiotou, 2012, Journal of clinical epidemiology.

Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study

John P A Ioannidis, Ioanna Tzoulaki, J. Ioannidis, 2011, BMJ : British Medical Journal.

Meta-analysis methods.

Thomas A Trikalinos, Georgia Salanti, John P A Ioannidis, 2008, Advances in genetics.

Strengthening the reporting of genetic risk prediction studies: the GRIPS statement

John P A Ioannidis, Muin J Khoury, Julian Little, 2011, European journal of clinical investigation.

Global estimates of high‐level brain drain and deficit

John P A Ioannidis, J. Ioannidis, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013

Lars Engebretsen, John P A Ioannidis, Willem van Mechelen, 2013, British Journal of Sports Medicine.

Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.

John P A Ioannidis, J. Ioannidis, Panagiotis N Papanikolaou, 2004, The American journal of medicine.

Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation.

Nikolaos A Patsopoulos, John P A Ioannidis, Evangelos Evangelou, 2008, International journal of epidemiology.

A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.

John P A Ioannidis, Evangelos Evangelou, J. Ioannidis, 2010, Journal of the National Cancer Institute.

Waste, Leaks, and Failures in the Biomarker Pipeline.

Patrick M M Bossuyt, John P A Ioannidis, J. Ioannidis, 2017, Clinical chemistry.

Meta‐research: The art of getting it wrong

John P A Ioannidis, J. Ioannidis, 2010, Research synthesis methods.

Evidence of reporting biases in voxel‐based morphometry (VBM) studies of psychiatric and neurological disorders

Andrea Mechelli, John P A Ioannidis, Joaquim Radua, 2013, Human brain mapping.

Assessing scientists for hiring, promotion, and tenure

David Moher, John P A Ioannidis, Steven N Goodman, 2018, PLoS biology.

Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research

John P A Ioannidis, Petros Isaakidis, J. Ioannidis, 2002, BMJ : British Medical Journal.

Curbing Unnecessary and Wasted Diagnostic Imaging.

John P A Ioannidis, Electron Kebebew, J. Ioannidis, 2019, JAMA.

Any casualties in the clash of randomised and observational evidence?

Anna-Bettina Haidich, John P A Ioannidis, J. Ioannidis, 2001, BMJ : British Medical Journal.

Clinical interpretation and implications of whole-genome sequencing.

Euan A Ashley, Michael Snyder, Michelle Whirl-Carrillo, 2014, JAMA.

Limitations are not properly acknowledged in the scientific literature.

John P A Ioannidis, J. Ioannidis, 2007, Journal of clinical epidemiology.

Adverse events in randomized trials: neglected, restricted, distorted, and silenced.

John P A Ioannidis, J. Ioannidis, 2009, Archives of internal medicine.

Comparisons of established risk prediction models for cardiovascular disease: systematic review

John P A Ioannidis, Ioanna Tzoulaki, George C M Siontis, 2012, BMJ : British Medical Journal.

A generalized view of self-citation: direct, co-author, collaborative, and coercive induced self-citation.

John P A Ioannidis, J. Ioannidis, 2015, Journal of psychosomatic research.

Evidence-based medicine has been hijacked: a report to David Sackett.

John P A Ioannidis, J. Ioannidis, 2016, Journal of clinical epidemiology.

How to use an article reporting a multiple treatment comparison meta-analysis.

Kristian Thorlund, Gordon H Guyatt, John P A Ioannidis, 2012, JAMA.

Ensuring the integrity of clinical practice guidelines: a tool for protecting patients

John P A Ioannidis, Jeanne Lenzer, J. Ioannidis, 2013, BMJ : British Medical Journal.

Meta-analysis in genome-wide association studies.

John P A Ioannidis, Eleftheria Zeggini, E. Zeggini, 2009, Pharmacogenomics.

F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis

John P A Ioannidis, Evangelos Evangelou, J. Ioannidis, 2008 .

A comparison of bivariate, multivariate random-effects, and Poisson correlated gamma-frailty models to meta-analyze individual patient data of ordinal scale diagnostic tests.

Mary A Whooley, John P A Ioannidis, Ian Shrier, 2017, Biometrical journal. Biometrische Zeitschrift.

Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis.

Thomas A Trikalinos, John P A Ioannidis, J. Ioannidis, 2002, Journal of the American College of Cardiology.

Improving Safety Reporting from Randomised Trials

John P A Ioannidis, J. Ioannidis, J. Lau, 2002, Drug safety.

Commentary: meta-analysis of individual participants' data in genetic epidemiology.

John P A Ioannidis, Philip S Rosenberg, James J Goedert, 2002, American journal of epidemiology.

Research needs grants, funding and money – missing something?

John P A Ioannidis, J. Ioannidis, 2012, European journal of clinical investigation.

Life Cycle of Translational Research for Medical Interventions

John P A Ioannidis, Despina G Contopoulos-Ioannidis, J. Ioannidis, 2008, Science.

Studying the elusive environment in large scale.

John P A Ioannidis, Chirag J Patel, J. Ioannidis, 2014, JAMA.

Selective Cutoff Reporting in Studies of Diagnostic Test Accuracy: A Comparison of Conventional and Individual-Patient-Data Meta-Analyses of the Patient Health Questionnaire-9 Depression Screening Tool

Mary A Whooley, Lorie A. Kloda, John P A Ioannidis, 2017, American journal of epidemiology.

A standardized citation metrics author database annotated for scientific field

Kevin W Boyack, John P A Ioannidis, Richard Klavans, 2019, PLoS biology.

An epidemic of false claims. Competition and conflicts of interest distort too many medical findings.

John P A Ioannidis, J. Ioannidis, 2011, Scientific American.

Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously.

John P A Ioannidis, J. Ioannidis, G. Stergiou, 2010, Hypertension.

Is molecular profiling ready for use in clinical decision making?

John P A Ioannidis, J. Ioannidis, 2007, The oncologist.

How to use a subgroup analysis: users' guide to the medical literature.

Thomas Agoritsas, John P A Ioannidis, Gordon Guyatt, 2014, JAMA.

Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling

Mukesh Verma, John P A Ioannidis, Muin J Khoury, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Almost all articles on cancer prognostic markers report statistically significant results.

John P A Ioannidis, J. Ioannidis, P. Kyzas, 2007, European journal of cancer.

Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects.

John P A Ioannidis, J. Ioannidis, 2006, Journal of the National Cancer Institute.

Genetic associations: false or true?

John P A Ioannidis, J. Ioannidis, 2003, Trends in molecular medicine.

Handling the fragile vase of scientific practices.

John P A Ioannidis, 2015, Addiction.

'Racial' differences in genetic effects for complex diseases

Thomas A Trikalinos, John P A Ioannidis, Evangelia E Ntzani, 2004, Nature Genetics.

Claims of sex differences: an empirical assessment in genetic associations.

Nikolaos A Patsopoulos, John P A Ioannidis, Athina Tatsioni, 2007, JAMA.

The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses

Lorie A. Kloda, John P A Ioannidis, Ian Shrier, 2014, Systematic Reviews.

Knowledge Integration in Cancer: Current Landscape and Future Prospects

John P A Ioannidis, Muin J Khoury, Sheri D Schully, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers

John P A Ioannidis, J. Ioannidis, 2009, Circulation. Cardiovascular genetics.

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Margaret Sutherland, John P A Ioannidis, Daniel Weintraub, 2015, The Lancet Neurology.

The power of meta-analysis in genome-wide association studies.

John P A Ioannidis, Cristen J Willer, Joel N Hirschhorn, 2013, Annual review of genomics and human genetics.

Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score.

John P A Ioannidis, George M Spyrou, Evangelos Evangelou, 2016, The Journal of investigative dermatology.

Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?

John P A Ioannidis, Peter C Gøtzsche, J. Ioannidis, 2012, BMJ : British Medical Journal.

Mapping the expanded often inappropriate use of the Framingham Risk Score in the medical literature.

John P A Ioannidis, Ioanna Tzoulaki, Evangelia E Ntzani, 2014, Journal of clinical epidemiology.

Guidelines for cardiovascular risk assessment and cholesterol treatment--reply.

John P A Ioannidis, J. Ioannidis, 2014, JAMA.

More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines.

John P A Ioannidis, J. Ioannidis, 2014, JAMA.

How to use an article about genetic association: A: Background concepts.

Ammarin Thakkinstian, Mark McEvoy, Rodney J Scott, 2009, JAMA.

Scientific inbreeding and same-team replication: type D personality as an example.

John P A Ioannidis, J. Ioannidis, 2012, Journal of psychosomatic research.

Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures.

John P A Ioannidis, J. Ioannidis, 2020, European journal of clinical investigation.

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Paolo Vineis, David H Phillips, Christopher Wild, 2011, Preventive medicine.

Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

John P A Ioannidis, Evangelos Evangelou, George Spyrou, 2011, Journal of the National Cancer Institute.

Expectations and challenges stemming from genome-wide association studies.

Paolo Vineis, Giuseppe Matullo, John P A Ioannidis, 2008, Mutagenesis.

Populating the Data Ark: An attempt to retrieve, preserve, and liberate data from the most highly-cited psychology and psychiatry articles

Tom E Hardwicke, John P A Ioannidis, J. Ioannidis, 2018, PloS one.

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

Caroline Gordon, John P A Ioannidis, Jürgen Floege, 2012, Annals of the rheumatic diseases.

Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time.

Rachel Churchill, Thomas A Trikalinos, John P A Ioannidis, 2004, Journal of clinical epidemiology.

Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials.

Thomas A Trikalinos, John P A Ioannidis, J. Ioannidis, 2005, Journal of clinical epidemiology.

Neglected tropical diseases: survey and geometry of randomised evidence

John P A Ioannidis, J. Ioannidis, Shanthi Kappagoda, 2012, BMJ : British Medical Journal.

Journals Should Publish All “Null” Results and Should Sparingly Publish “Positive” Results

John P A Ioannidis, J. Ioannidis, 2006, Cancer Epidemiology Biomarkers & Prevention.

Population-wide generalizability of genome-wide discovered associations.

John P A Ioannidis, J. Ioannidis, 2009, Journal of the National Cancer Institute.

Plea for routinely presenting prediction intervals in meta-analysis

Jelle J Goeman, John P A Ioannidis, Maroeska M Rovers, 2016, BMJ Open.

Optimal type I and type II error pairs when the available sample size is fixed.

John P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic, 2013, Journal of clinical epidemiology.

Reversals of established medical practices: evidence to abandon ship.

John P A Ioannidis, Vinay Prasad, J. Ioannidis, 2012, JAMA.

Number of published systematic reviews and global burden of disease: database analysis

John P A Ioannidis, J. Ioannidis, G. Swingler, 2003, BMJ : British Medical Journal.

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database

John P A Ioannidis, Muin J Khoury, Lars Bertram, 2008, Nature Genetics.

Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.

Georgia Salanti, John P A Ioannidis, Davide Mauri, 2008, Journal of the National Cancer Institute.

Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases.

Thomas A Trikalinos, John P A Ioannidis, Muin J Khoury, 2006, American journal of epidemiology.

Uncertainty in heterogeneity estimates in meta-analyses

Nikolaos A Patsopoulos, John P A Ioannidis, Evangelos Evangelou, 2007, BMJ : British Medical Journal.

The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.

John P A Ioannidis, J. Ioannidis, 2016, The Milbank quarterly.

What makes a good predictor?: the evidence applied to coronary artery calcium score.

John P A Ioannidis, Ioanna Tzoulaki, J. Ioannidis, 2010, JAMA.

Improving the drug development process: more not less randomized trials.

John P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic, 2014, JAMA.

A network of investigator networks in human genome epidemiology.

Paolo Vineis, Julian P T Higgins, Georgia Salanti, 2005, American journal of epidemiology.

The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis.

Thomas A Trikalinos, John P A Ioannidis, J. Ioannidis, 2003, Kidney international.

Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers.

John P A Ioannidis, Evangelos Evangelou, J. Ioannidis, 2008, Journal of clinical epidemiology.

The effects of excluding treatments from network meta-analyses: survey

Kristian Thorlund, Anna Chaimani, John P A Ioannidis, 2013, BMJ : British Medical Journal.

What Should the Genome-wide Significance Threshold Be? Empirical Replication of Borderline Genetic Associations Yfor a Full List of Investigators Offering Data and Clarifications See Acknowledgments

John P A Ioannidis, J. Ioannidis, O. Panagiotou, 2022 .

Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity

Nikolaos A Patsopoulos, Georgia Salanti, John P A Ioannidis, 2010, Research synthesis methods.

Selective discussion and transparency in microarray research findings for cancer outcomes.

Thomas A Trikalinos, John P A Ioannidis, J. Ioannidis, 2007, European journal of cancer.

Overlapping meta-analyses on the same topic: survey of published studies

Tina Hernandez-Boussard, John P A Ioannidis, J. Ioannidis, 2013, BMJ.

Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations.

Thomas A Trikalinos, Georgia Salanti, John P A Ioannidis, 2006, American journal of epidemiology.

Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer.

John P A Ioannidis, J. Ioannidis, T. Dragani, 2010, Trends in genetics : TIG.

Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.

Georgia Salanti, John P A Ioannidis, Vassilis Golfinopoulos, 2007, The Lancet. Oncology.

The Reproducibility Wars: Successful, Unsuccessful, Uninterpretable, Exact, Conceptual, Triangulated, Contested Replication.

John P A Ioannidis, J. Ioannidis, 2017, Clinical chemistry.